RSV1.org
RSV isn’t Just a cold
It can become serious
STARTS
LIKE A COLD¹
For some, RSV can progress to pneumonia, severe respiratory illness, and hospitalization.
OVER 180,000
Hospitalizations²
Adults are hospitalized with RSV each year in the US
ONE
Dose³
Can help reduce the risk of severe RSV hospitalization.
Explore your options about RSV Vaccines
Three RSV vaccines are currently available:
ABRYSVO® (Pfizer), AREXVY® (GSK), and mRESVIA® (Moderna).
Explore each vaccine to learn more, and talk with your healthcare professional about which vaccine, if any, may be appropriate for you.
2. —> And, is the person you care about…⁴
Age 50 or older?
1. —> Does someone you love have any of these chronic health conditions?⁴
Heart Disease
Lung Disease
Diabetes
Kidney Disease
Weakened Immunity
Severe Obesity
RSV could be more
serious for them.
What does RSV Feel Like?
Day 1–3⁵
Runny nose
Cough
Fatigue
↓
For some adults it becomes⁵
Difficulty breathing
Wheezing
Pneumonia
Hospitalization
Don’t wait until RSV
becomes serious
Sources
1. Centers for Disease Control and Prevention. RSV in Older Adults and Adults at Increased Risk. Updated February 20, 2026.
2. Centers for Disease Control and Prevention. Clinical Overview of RSV. Updated August 18, 2025.
3. Centers for Disease Control and Prevention. RSVVaxView: Weekly RSV Vaccination Dashboard. Updated May 20, 2026.
4. Centers for Disease Control and Prevention. RSV Vaccine Guidance for Older Adults. Updated June 26, 2025.
5. Centers for Disease Control and Prevention. RSVVaxView: Weekly RSV Vaccination Dashboard. Updated May 20, 2026.
Learn the risk.
Understand whether you or someone you care about may be at an increased risk for severe RSV illness.
↓
Talk with a healthcare professional.
Ask whether RSV vaccination is recommended based on age and health conditions.⁴
↓
Help protect what matters.
For eligible adults, RSV vaccination is currently recommended as a one-time vaccine.⁴
RSV1
RSV1 is a public education campaign of the Alliance for Health Implementation Science (AHIS), a nonprofit organization dedicated to helping more people benefit from therapies, treatments, and trials.
AHIS develops educational resources based on current scientific evidence and clinical recommendations from recognized public health and professional organizations. Our goal is to help people have informed conversations with their healthcare professionals about RSV prevention and vaccination.
AHIS does not compare or recommend one manufacturer's RSV vaccine over another. Clinical decisions should always be made in consultation with a qualified healthcare professional.
Bring RSV1 to your community and extend the impact of the RSV work you're already doing.
RSV1 gives organizations another way to reach and engage the people they serve—while keeping their own brand, voice, expertise, and resources at the center.
Community Partners can use RSV1 to amplify existing education and resources, reach new audiences, participate in or host conversations and community activations, and connect people to trusted next steps—including their own programs and resources where appropriate.
Focus on the Patient, Rabble Health's media and community engagement platform, provides the media, campaign, and community activation infrastructure that makes this possible.